Agile Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Agile Therapeutics Inc
CIK #0001261249
EDGAR Form CIK 2011 - 2026
10-K [0001261249]
10-Q [0001261249]
3 [0001261249]
4 [0001261249]
8-K [0001261249]
D [0001261249]
SC 13D [0001261249]
SC 13G [0001261249]
Form 13D/13G Filer Form 13D/13G Subject Filed
Mastrangeli Doug Agile Therapeutics Inc [2024-08-26]
Tang Capital Partners LP Agile Therapeutics Inc [2024-07-22]
Beryl Capital Management LLC Agile Therapeutics Inc [2024-07-09]
Klein Roger M Agile Therapeutics Inc [2024-07-02]
Lind Global Fund II LP Agile Therapeutics Inc [2022-07-12]
Intracoastal Capital LLC Agile Therapeutics Inc [2022-07-11]
Vanguard Group Inc Agile Therapeutics Inc [2021-02-10]
BlackRock Inc Agile Therapeutics Inc [2021-02-02]
Perceptive Advisors LLC Agile Therapeutics Inc [2019-03-06]
Renaissance Technologies LLC Agile Therapeutics Inc [2019-02-12]
View All
Form 3/4/5 Subject 2011 - 2026
Agile Therapeutics Inc
Conway Robert G
Welsh Amy
Korner Paul
Hubbard John W
Fischer Seth H Z
Altomari Alfred
Carson Sandra
Barbari Sharon
Gilmore Geoffrey
Coiante Scott M
Torrente Josephine
Butch Jason
Shetty Ajit
Tursi James Patrick
Reilly Dennis
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Lele Abhijeet J
McKee William
Garner Elizabeth
Care Capital Offshore Investments III LP
Care Capital III LLC
Care Capital Investments III LP
Selman Renee
Hong Karen
Elms Steve
Aisling Capital Partners III LP
Schiff Andrew N
Aisling Capital III LP
Aisling Capital Partners III LLC
Purcell Dennis J
MacFarlane Katie
ProQuest Investments IV LP
Moorin Jay
ProQuest Associates IV LLC
ProQuest Associates III LLC
Schreiber Alain
ProQuest Investments III LP
Investor AB
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 10,131 $1.52 15,399
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 10,125 $1.52 15,390
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 13 $1.52 20
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 974 $1.52 1,480
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 973 $1.52 1,479
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 973 $1.52 1,479
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 19,624 $1.52 29,828
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 28,125 $1.52 42,750
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 976 $1.52 1,484
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 976 $1.52 1,484
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 5,080 $1.52 7,722
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 15,000 $1.52 22,800
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 3,404 $1.52 5,174
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 10,125 $1.52 15,390
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 10,125 $1.52 15,390
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 10,125 $1.52 15,390
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 3,375 $1.52 5,130
Agile Therapeutics Inc AGRX
Common Stock
2024-08-26 Disposed to issuer 3,375 $1.52 5,130
Agile Therapeutics Inc AGRX
Common Stock
2023-10-03 Grant 20,000 $0.00
Agile Therapeutics Inc AGRX
Employee Stock Option (Right to Buy) · derivative
2023-06-28 Grant 12,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com